On December 28, upon the review of China NMPA, the product SARS-CoV-2 antigen detection reagent of Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. is approved for marketing. Up until now, NMPA has approved 48 SARS-CoV-2 antigen test kits.

　　The NMPA will strengthen the post-marketing surveillance of relevant products to protect the safety of medical devices used by patients.

　　Annex: SARS-CoV-2 antigen test kits approved by NMPA